Hypoxia-inducible factor 1 (HIF-1), which is generally regarded as a tumor prospective factor related to tumor cell proliferation, apoptosis, metabolism, and angiogenesis, is one of the most compelling targets for treating cancers [42]. Here, SETD2 is linked to neoplasm.